Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 385

1.

The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 kinase via pyrimidine depletion.

Dembitz V, Tomic B, Kodvanj I, Simon JA, Bedalov A, Visnjic D.

J Biol Chem. 2019 Aug 20. pii: jbc.RA119.009396. doi: 10.1074/jbc.RA119.009396. [Epub ahead of print]

2.

ORC-13661 protects sensory hair cells from aminoglycoside and cisplatin ototoxicity.

Kitcher SR, Kirkwood NK, Camci ED, Wu P, Gibson RM, Redila VA, Simon JA, Rubel EW, Raible DW, Richardson GP, Kros CJ.

JCI Insight. 2019 Aug 8;4(15). pii: 126764. doi: 10.1172/jci.insight.126764. eCollection 2019 Aug 8.

3.

Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.

Bilezikian JP, Lin CJF, Brown JP, Wang AT, Yin X, Ebeling PR, Fahrleitner-Pammer A, Franek E, Gilchrist N, Miller PD, Simon JA, Valter I, Zerbini CAF, Libanati C, Chines A.

Osteoporos Int. 2019 Jun 14. doi: 10.1007/s00198-019-05020-8. [Epub ahead of print]

PMID:
31201481
4.

Weight Loss in Women Taking Flibanserin for Hypoactive Sexual Desire Disorder (HSDD): Insights Into Potential Mechanisms.

Simon JA, Kingsberg SA, Goldstein I, Kim NN, Hakim B, Millheiser L.

Sex Med Rev. 2019 Jun 10. pii: S2050-0521(19)30039-3. doi: 10.1016/j.sxmr.2019.04.003. [Epub ahead of print] Review.

PMID:
31196764
5.

Fate plasticity and reprogramming in genetically distinct populations of Danio leucophores.

Lewis VM, Saunders LM, Larson TA, Bain EJ, Sturiale SL, Gur D, Chowdhury S, Flynn JD, Allen MC, Deheyn DD, Lee JC, Simon JA, Lippincott-Schwartz J, Raible DW, Parichy DM.

Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11806-11811. doi: 10.1073/pnas.1901021116. Epub 2019 May 28.

6.

Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices.

Goldstein I, Simon JA, Kaunitz AM, Altomare C, Yoshida Y, Zhu J, Schaffer S, Soulban G.

Menopause. 2019 May 20. doi: 10.1097/GME.0000000000001350. [Epub ahead of print]

PMID:
31124912
7.

TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women.

Simon JA, Kagan R, Archer DF, Constantine GD, Bernick B, Graham S, Mirkin S.

Climacteric. 2019 Aug;22(4):412-418. doi: 10.1080/13697137.2019.1577379. Epub 2019 Mar 12.

PMID:
30862193
8.

Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part III.

Parish SJ, Meston CM, Althof SE, Clayton AH, Goldstein I, Goldstein SW, Heiman JR, McCabe MP, Segraves RT, Simon JA.

J Sex Med. 2019 Mar;16(3):452-462. doi: 10.1016/j.jsxm.2019.01.010.

PMID:
30846116
9.

Descriptors of Vulvodynia: A Multisocietal Definition Consensus (International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women Sexual Health, and the International Pelvic Pain Society).

Bornstein J, Preti M, Simon JA, As-Sanie S, Stockdale CK, Stein A, Parish SJ, Radici G, Vieira-Baptista P, Pukall C, Moyal-Barracco M, Goldstein A; International Society for the Study of Vulvovaginal Disease (ISSVD), the International Society for the Study of Womenʼs Sexual Health (ISSWSH), and the International Pelvic Pain Society (IPPS).

J Low Genit Tract Dis. 2019 Apr;23(2):161-163. doi: 10.1097/LGT.0000000000000461.

PMID:
30768446
10.

Female Sexual Health: Barriers to Optimal Outcomes and a Roadmap for Improved Patient-Clinician Communications.

Kingsberg SA, Schaffir J, Faught BM, Pinkerton JV, Parish SJ, Iglesia CB, Gudeman J, Krop J, Simon JA.

J Womens Health (Larchmt). 2019 Apr;28(4):432-443. doi: 10.1089/jwh.2018.7352. Epub 2019 Feb 4.

11.

Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.

Simon JA, Thorp J, Millheiser L.

J Womens Health (Larchmt). 2019 Jun;28(6):769-777. doi: 10.1089/jwh.2018.7516. Epub 2019 Feb 1.

PMID:
30707049
12.

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial.

Archer DF, Goldstein SR, Simon JA, Waldbaum AS, Sussman SA, Altomare C, Zhu J, Yoshida Y, Schaffer S, Soulban G.

Menopause. 2019 Jan 28;26(6):611-621. doi: 10.1097/GME.0000000000001292.

13.

Women's experience of vulvovaginal symptoms associated with menopause.

Shifren JL, Zincavage R, Cho EL, Magnavita A, Portman DJ, Krychman ML, Simon JA, Kingsberg SA, Rosen RC.

Menopause. 2019 Apr;26(4):341-349. doi: 10.1097/GME.0000000000001275.

PMID:
30531443
14.

Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms.

Constantine GD, Revicki DA, Kagan R, Simon JA, Graham S, Bernick B, Mirkin S.

Menopause. 2019 May;26(5):513-519. doi: 10.1097/GME.0000000000001261.

15.

Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.

Simon JA, Kaunitz AM, Kroll R, Graham S, Bernick B, Mirkin S.

Menopause. 2019 May;26(5):506-512. doi: 10.1097/GME.0000000000001271.

16.

Female Sexual Dysfunction and the Placebo Effect: A Meta-analysis.

Kingsberg S, Goldstein I, Kim NN, Simon JA.

Obstet Gynecol. 2018 Dec;132(6):1504. doi: 10.1097/AOG.0000000000002985. No abstract available.

PMID:
30461675
17.

Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.

Carr BR, Stewart EA, Archer DF, Al-Hendy A, Bradley L, Watts NB, Diamond MP, Gao J, Owens CD, Chwalisz K, Duan WR, Soliman AM, Dufek MB, Simon JA.

Obstet Gynecol. 2018 Nov;132(5):1252-1264. doi: 10.1097/AOG.0000000000002933.

PMID:
30303923
18.

Wearable Cardioverter-Defibrillator after Myocardial Infarction.

Olgin JE, Pletcher MJ, Vittinghoff E, Wranicz J, Malik R, Morin DP, Zweibel S, Buxton AE, Elayi CS, Chung EH, Rashba E, Borggrefe M, Hue TF, Maguire C, Lin F, Simon JA, Hulley S, Lee BK; VEST Investigators.

N Engl J Med. 2018 Sep 27;379(13):1205-1215. doi: 10.1056/NEJMoa1800781.

19.

Estradiol vaginal inserts (4 µg and 10 µg) for treating moderate to severe vulvar and vaginal atrophy: a review of phase 3 safety, efficacy and pharmacokinetic data.

Constantine GD, Simon JA, Pickar JH, Archer DF, Bernick B, Graham S, Mirkin S.

Curr Med Res Opin. 2018 Dec;34(12):2131-2136. doi: 10.1080/03007995.2018.1527578. Epub 2018 Sep 28.

PMID:
30238814
20.

In Reply.

Faubion SS, Larkin LC, Simon JA, Kingsberg SA.

Menopause. 2019 Feb;26(2):227-228. doi: 10.1097/GME.0000000000001191. No abstract available.

PMID:
30204639
21.

Sexual well-being after menopause: An International Menopause Society White Paper.

Simon JA, Davis SR, Althof SE, Chedraui P, Clayton AH, Kingsberg SA, Nappi RE, Parish SJ, Wolfman W.

Climacteric. 2018 Oct;21(5):415-427. doi: 10.1080/13697137.2018.1482647. Epub 2018 Jul 10.

PMID:
29987939
22.

In Reply.

Simon JA.

Obstet Gynecol. 2018 Jul;132(1):215-216. doi: 10.1097/AOG.0000000000002704. No abstract available.

PMID:
29939916
23.

Treatments for Hypoactive Sexual Desire Disorder (HSDD) and the Pursuit of Sexual Health for Women amidst Inglorious Rhetoric.

Kim NN, Goldstein I, Larkin L, Kellogg-Spadt S, Simon JA.

Sex Med Rev. 2018 Jul;6(3):339-342. doi: 10.1016/j.sxmr.2018.06.001. Epub 2018 Jun 15. No abstract available.

PMID:
29914753
24.

Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies.

Surrey E, Taylor HS, Giudice L, Lessey BA, Abrao MS, Archer DF, Diamond MP, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Singh SS, Rechberger T, Agarwal SK, Duan WR, Schwefel B, Thomas JW, Peloso PM, Ng J, Soliman AM, Chwalisz K.

Obstet Gynecol. 2018 Jul;132(1):147-160. doi: 10.1097/AOG.0000000000002675.

PMID:
29889764
25.

A multi-event capture-recapture analysis of Toxoplasma gondii seroconversion dynamics in farm cats.

Simon JA, Pradel R, Aubert D, Geers R, Villena I, Poulle ML.

Parasit Vectors. 2018 Jun 8;11(1):339. doi: 10.1186/s13071-018-2834-4.

26.

The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review.

Simon JA, Goldstein I, Kim NN, Davis SR, Kellogg-Spadt S, Lowenstein L, Pinkerton JV, Stuenkel CA, Traish AM, Archer DF, Bachmann G, Goldstein AT, Nappi RE, Vignozzi L.

Menopause. 2018 Jul;25(7):837-847. doi: 10.1097/GME.0000000000001138.

PMID:
29870471
27.

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health.

Faubion SS, Larkin LC, Stuenkel CA, Bachmann GA, Chism LA, Kagan R, Kaunitz AM, Krychman ML, Parish SJ, Partridge AH, Pinkerton JV, Rowen TS, Shapiro M, Simon JA, Goldfarb SB, Kingsberg SA.

Menopause. 2018 Jun;25(6):596-608. doi: 10.1097/GME.0000000000001121.

PMID:
29762200
28.

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting.

Afram G, Simón JAP, Remberger M, Caballero-Velázquez T, Martino R, Piñana JL, Ringden O, Esquirol A, Lopez-Corral L, Garcia I, López-Godino O, Sierra J, Caballero D, Ljungman P, Vazquez L, Hägglund H.

Med Oncol. 2018 Apr 25;35(6):79. doi: 10.1007/s12032-018-1127-2.

29.

Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause.

Traish AM, Vignozzi L, Simon JA, Goldstein I, Kim NN.

Sex Med Rev. 2018 Oct;6(4):558-571. doi: 10.1016/j.sxmr.2018.03.005. Epub 2018 Apr 7. Review.

30.

Inhibition of vaccinia virus replication by nitazoxanide.

Hickson SE, Margineantu D, Hockenbery DM, Simon JA, Geballe AP.

Virology. 2018 May;518:398-405. doi: 10.1016/j.virol.2018.03.023. Epub 2018 Apr 3.

31.

Perioperative Care of the Breastfeeding Patient.

Simon JA, Carabetta M, Rieth EF, Barnett KM.

AORN J. 2018 Apr;107(4):465-474. doi: 10.1002/aorn.12101.

PMID:
29595905
32.

The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women.

Clayton AH, Goldstein I, Kim NN, Althof SE, Faubion SS, Faught BM, Parish SJ, Simon JA, Vignozzi L, Christiansen K, Davis SR, Freedman MA, Kingsberg SA, Kirana PS, Larkin L, McCabe M, Sadovsky R.

Mayo Clin Proc. 2018 Apr;93(4):467-487. doi: 10.1016/j.mayocp.2017.11.002. Epub 2018 Mar 12. Review.

33.

Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.

Simon JA, Derogatis L, Portman D, Brown L, Yuan J, Kissling R.

J Sex Med. 2018 Mar;15(3):387-395. doi: 10.1016/j.jsxm.2017.12.016.

PMID:
29502984
34.

Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial.

Simon JA, Catherino W, Segars JH, Blakesley RE, Chan A, Sniukiene V, Al-Hendy A.

Obstet Gynecol. 2018 Mar;131(3):431-439. doi: 10.1097/AOG.0000000000002462.

PMID:
29420395
35.

Sexual Function Post-Breast Cancer.

Streicher L, Simon JA.

Cancer Treat Res. 2018;173:167-189. doi: 10.1007/978-3-319-70197-4_11. Review.

PMID:
29349764
36.

Implementation and Organization of a Perioperative Lactation Program: A Descriptive Study.

Rieth EF, Barnett KM, Simon JA.

Breastfeed Med. 2018 Mar;13(2):97-105. doi: 10.1089/bfm.2017.0193. Epub 2017 Dec 22.

37.

A Role for Monomethylation of Histone H3-K27 in Gene Activity in Drosophila.

Wang L, Joshi P, Miller EL, Higgins L, Slattery M, Simon JA.

Genetics. 2018 Mar;208(3):1023-1036. doi: 10.1534/genetics.117.300585. Epub 2017 Dec 14.

38.

Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14.

Kingsberg SA, Althof S, Simon JA, Bradford A, Bitzer J, Carvalho J, Flynn KE, Nappi RE, Reese JB, Rezaee RL, Schover L, Shifrin JL.

J Sex Med. 2017 Dec;14(12):1463-1491. doi: 10.1016/j.jsxm.2017.05.018. Review. Erratum in: J Sex Med. 2018 Feb;15(2):270.

PMID:
29198504
39.

Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials.

Simon JA, Altomare C, Cort S, Jiang W, Pinkerton JV.

J Womens Health (Larchmt). 2018 Jan;27(1):14-23. doi: 10.1089/jwh.2017.6385. Epub 2017 Oct 24.

40.

Phenotypic Optimization of Urea-Thiophene Carboxamides To Yield Potent, Well Tolerated, and Orally Active Protective Agents against Aminoglycoside-Induced Hearing Loss.

Chowdhury S, Owens KN, Herr RJ, Jiang Q, Chen X, Johnson G, Groppi VE, Raible DW, Rubel EW, Simon JA.

J Med Chem. 2018 Jan 11;61(1):84-97. doi: 10.1021/acs.jmedchem.7b00932. Epub 2017 Oct 27.

41.

Clinical trials in menopause.

Marko KI, Simon JA.

Menopause. 2018 Feb;25(2):217-230. doi: 10.1097/GME.0000000000000978. Review.

PMID:
28953214
42.

An Unusual Cause of an Isolated Transient Ischemic Attack in an Otherwise Healthy Elderly Man.

Freed JK, Simon JA, Iqbal Z, Almassi GH, Pagel PS.

J Cardiothorac Vasc Anesth. 2018 Jun;32(3):1529-1532. doi: 10.1053/j.jvca.2017.06.008. Epub 2017 Sep 15. No abstract available.

PMID:
28927695
43.

Hypnosis for Smoking Relapse Prevention: A Randomized Trial.

Carmody TP, Duncan CL, Solkowitz SN, Huggins J, Simon JA.

Am J Clin Hypn. 2017 Oct;60(2):159-171. doi: 10.1080/00029157.2016.1261678.

PMID:
28891777
44.

Distressing Sexual Function at Midlife: Unmet Needs, Practical Diagnoses, and Available Treatments.

Simon JA, Lukas VA.

Obstet Gynecol. 2017 Oct;130(4):889-905. doi: 10.1097/AOG.0000000000002268.

PMID:
28885410
45.

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

Langer RD, Simon JA, Pines A, Lobo RA, Hodis HN, Pickar JH, Archer DF, Sarrel PM, Utian WH.

Menopause. 2017 Oct;24(10):1101-1112. doi: 10.1097/GME.0000000000000983. No abstract available.

PMID:
28872490
46.

Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis.

Kornstein SG, Simon JA, Apfel SC, Yuan J, Barbour KA, Kissling R.

J Womens Health (Larchmt). 2017 Nov;26(11):1161-1168. doi: 10.1089/jwh.2016.6230. Epub 2017 Aug 17.

47.

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

Langer RD, Simon JA, Pines A, Lobo RA, Hodis HN, Pickar JH, Archer DF, Sarrel PM, Utian WH.

Climacteric. 2017 Oct;20(5):402-413. doi: 10.1080/13697137.2017.1362156. Epub 2017 Aug 14. Erratum in: Climacteric. 2017 Oct;20(5):503.

PMID:
28805475
48.

Correction for Wang et al., "Comparative Analysis of Chromatin Binding by Sex Comb on Midleg (SCM) and Other Polycomb Group Repressors at a Drosophila Hox Gene".

Wang L, Jahren N, Miller EL, Ketel CS, Mallin DR, Simon JA.

Mol Cell Biol. 2017 Jul 14;37(15). pii: e00148-17. doi: 10.1128/MCB.00148-17. Print 2017 Aug 1. No abstract available.

49.

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.

Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, Diamond MP, Surrey E, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Rowan JP, Duan WR, Ng J, Schwefel B, Thomas JW, Jain RI, Chwalisz K.

N Engl J Med. 2017 Jul 6;377(1):28-40. doi: 10.1056/NEJMoa1700089. Epub 2017 May 19.

50.

"Did You Climax or Are You Just Laughing at Me?" Rare Phenomena Associated With Orgasm.

Reinert AE, Simon JA.

Sex Med Rev. 2017 Jul;5(3):275-281. doi: 10.1016/j.sxmr.2017.03.004. Epub 2017 Apr 25. Review.

PMID:
28454896

Supplemental Content

Loading ...
Support Center